Evidence-Based GI: An ACG Publication and Podcast

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Colin Howden, MD discuss “ACG Clinical Guideline: Treatment of Helicobacter pylori Infection,” by Chey W, Howden C, Moss S, et al. Am J Gastroenterol. 2024;119:1730-53.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Rahul Dalal, MD, MPH discuss “Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials,” by Louis E, Schreiber S, Panaccione R, Bossuyt P, et al for the INSPIRE and COMMAND Study Group. JAMA. 2024 Jul 22:e2412414

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Ahmad Abu-Heija, MBBS discuss “Standardised training for endoscopic mucosal resection of large non-pedunculated colorectal polyps to reduce recurrence (*STAR-LNPCP study): a multicentre cluster randomised trial,” by Meulen LWT, Bogie RMM, Siersema PD, et al. Gut. 2024 Apr 5;73(5):741-750

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Swathi Eluri, MD, MSCR discuss “Diagnostic Yield of Ambulatory Reflux Monitoring Systems for Evaluation of Chronic Laryngeal Symptoms,” by Krause AJ, Greytak M, Kaizer MA, et al. Am J Gastroenterol. 2024 Apr 1;119(4):627-634.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Bharati Kochar, MD, MS discuss “Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease,” by Peyrin-Biroulet L, Chapman JC, Colombel JF, et al. N Engl J Med 2024;391:213-223.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Christopher Velez, MD discuss “Vonoprazan is Efficacious for Treatment of Heartburn in Non-erosive Reflux Disease: A Randomized Trial,” by Laine L, Spechler S, and Yadlapati R et al. Clinical Gastroenterology and Hepatology 2024; In Press.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Margaret J. Zhou, MD, MS discuss “Extracorporeal Shock-Wave Lithotripsy and Endoscopy for the Treatment of Pain in Chronic Pancreatitis : A Sham-Controlled, Randomized Trial,” by Talukdar R, Olesen SS, Unnisa M et al. Ann Intern Med 2024 Jun;177(6):749-758.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Elie Al Kazzi, MD, MPH discuss “ACG Clinical Guideline: Gastroparesis,” by Camilleri M, Kuo B, Nguyen L, et al. Am J Gastroenterol 2022;117(8):1197-1220.

Philip Schoenfeld, MD, MSEd, MSc (Epi) discusses “Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis,” by Loomba R, Hartman ML, Lawitz EJ, et al. N Engl J Med June 8, 2024.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “Comparison of vonoprazan vs intravenous proton pump inhibitor for prevention of high-risk peptic ulcers rebleeding after successful endoscopic hemostasis: a multicenter randomized noninferiority trial,” by Geeratragool T, Kaosombatwattana U, Boonchote A, et al. Gastroenterology 2024; In Press.